Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Viskin

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of Cardiovascular Electrophysiology|June 1, 1993
Idiopathic ventricular tachycardia and fibrillationB Belhassen, S Viskin
Pacing and Clinical Electrophysiology : PACE|June 1, 1994
Should electrophysiological studies be performed in asymptomatic patients following myocardial infarction? A pragmatic approachS Viskin, B Belhassen
Pacing and Clinical Electrophysiology : PACE|August 1, 1993
What is the drug of choice for the acute termination of paroxysmal supraventricular tachycardia: verapamil, adenosine triphosphate, or adenosine?B Belhassen, S Viskin
Drugs|September 1, 1992
Noninvasive and invasive strategies for the prevention of sudden death after myocardial infarction. Value, limitations and implications for therapyS Viskin, B Belhassen
The New England Journal of Medicine|May 4, 1995
Clinical problem-solving. When you only live twiceS Viskin, B Belhassen
Progress in Cardiovascular Diseases|August 26, 1998
Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implications for therapyS Viskin, B Belhassen
American Heart Journal|July 1, 1990
Acute management of paroxysmal atrioventricular junctional reentrant supraventricular tachycardia: pharmacologic strategiesS Viskin, B Belhassen
Circulation|April 1, 1998
Increased vagal activity in idiopathic VFS Viskin, B Belhassen
Lancet (London, England)|March 3, 1998
Autonomic markers and prediction of cardiac death after myocardial infarctionH V Barron, S Viskin
Journal of Cardiovascular Electrophysiology|April 21, 1999
Management of intermittent atrial fibrillation: drugs to maintain sinus rhythmJ E Olgin, S Viskin
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of Cardiovascular Electrophysiology|June 1, 1993
Idiopathic ventricular tachycardia and fibrillationB Belhassen, S Viskin
Pacing and Clinical Electrophysiology : PACE|June 1, 1994
Should electrophysiological studies be performed in asymptomatic patients following myocardial infarction? A pragmatic approachS Viskin, B Belhassen
Pacing and Clinical Electrophysiology : PACE|August 1, 1993
What is the drug of choice for the acute termination of paroxysmal supraventricular tachycardia: verapamil, adenosine triphosphate, or adenosine?B Belhassen, S Viskin
Drugs|September 1, 1992
Noninvasive and invasive strategies for the prevention of sudden death after myocardial infarction. Value, limitations and implications for therapyS Viskin, B Belhassen
The New England Journal of Medicine|May 4, 1995
Clinical problem-solving. When you only live twiceS Viskin, B Belhassen
Progress in Cardiovascular Diseases|August 26, 1998
Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implications for therapyS Viskin, B Belhassen
American Heart Journal|July 1, 1990
Acute management of paroxysmal atrioventricular junctional reentrant supraventricular tachycardia: pharmacologic strategiesS Viskin, B Belhassen
Circulation|April 1, 1998
Increased vagal activity in idiopathic VFS Viskin, B Belhassen
Lancet (London, England)|March 3, 1998
Autonomic markers and prediction of cardiac death after myocardial infarctionH V Barron, S Viskin
Journal of Cardiovascular Electrophysiology|April 21, 1999
Management of intermittent atrial fibrillation: drugs to maintain sinus rhythmJ E Olgin, S Viskin
Pageof 6